RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth

PLoS ONE - United States
doi 10.1371/journal.pone.0048548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

miR-99a-5p Acts as Tumor Suppressor via Targeting to mTOR and Enhances RAD001-induced Apoptosis in Human Urinary Bladder Urothelial Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2013English

NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

Dual Inhibition of ULK1 and mTOR Enhances Tumor Cell Apoptosis

Cancer Discovery
Oncology
2015English

BEZ235 Impairs Gastric Cancer Growth by Inhibition of PI3K/mTOR in Vitro and in Vivo

BMC Pharmacology
2010English

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

FTY720 Inhibits Tumor Growth and Enhances the Tumor-Suppressive Effect of Topotecan in Neuroblastoma by Interfering With the Sphingolipid Signaling Pathway

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2013English

The Journey of Metformin From Glycaemic Control to mTOR Inhibition and the Suppression of Tumor Growth

British Journal of Clinical Pharmacology
Pharmacology
2018English

Bursts of Bipolar Microsecond Pulses Inhibit Tumor Growth

Scientific Reports
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy